Focus Partners Advisor Solutions’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Focus Partners Advisor Solutions's GILD Position: Q1 2026 in Review
Focus Partners Advisor Solutions sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 9,510 shares — an estimated $1.17M sold.
Focus Partners Advisor Solutions first reported a position in GILD in Q2 2022 and held it in 14 quarters. The position peaked at $1.17M in Q4 2025. 2,327 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Focus Partners Advisor Solutions reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
- Focus Partners Advisor Solutions sold 9,510 Gilead Sciences shares in Q1 2026, an estimated $1.17M.
- Focus Partners Advisor Solutions first reported a position in Gilead Sciences in Q2 2022 and held it in 14 quarters.
- Focus Partners Advisor Solutions's Gilead Sciences position peaked at $1.17M in Q4 2025.
- 2,327 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Focus Partners Advisor Solutions's 13F filing for Q1 2026, filed 13 May 2026.